These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18651811)

  • 1. Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
    McCullers JA; English BK
    Future Microbiol; 2008 Aug; 3(4):397-404. PubMed ID: 18651811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical feature of 23 cases of combined influenza virus and bacterial pneumonia].
    Suzuki Y; Gemma H; Satoh M; Koshimizu N; Suda T; Chida K
    Nihon Kokyuki Gakkai Zasshi; 2007 Sep; 45(9):667-72. PubMed ID: 17929467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza.
    Metersky ML; Masterton RG; Lode H; File TM; Babinchak T
    Int J Infect Dis; 2012 May; 16(5):e321-31. PubMed ID: 22387143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Using antibiotics in case of influenza].
    Chidiac C; Maulin L
    Med Mal Infect; 2006 Apr; 36(4):181-9. PubMed ID: 16600551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants.
    Lipsitch M; Hernán MA
    Clin Infect Dis; 2013 Nov; 57(9):1368-9. PubMed ID: 23883518
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial complications during pandemic influenza infection.
    Hussell T; Wissinger E; Goulding J
    Future Microbiol; 2009 Apr; 4(3):269-72. PubMed ID: 19327113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia.
    Wright PF; Kirkland KB; Modlin JF
    N Engl J Med; 2009 Dec; 361(24):e112. PubMed ID: 19940288
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Chung DR; Huh K
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):197-207. PubMed ID: 25578884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuraminidase inhibitors and risk of H5N1 influenza].
    Gras-Masse H; Willand N
    Ann Pharm Fr; 2007 Jan; 65(1):50-7. PubMed ID: 17299351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease.
    Sethi S
    Geriatrics; 2002 Mar; 57(3):56-61. PubMed ID: 11899549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
    Peltola VT; Murti KG; McCullers JA
    J Infect Dis; 2005 Jul; 192(2):249-57. PubMed ID: 15962219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials.
    Falagas ME; Koletsi PK; Vouloumanou EK; Rafailidis PI; Kapaskelis AM; Rello J
    J Antimicrob Chemother; 2010 Jul; 65(7):1330-46. PubMed ID: 20488984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The smaller number of influenza patients with neuropsychiatric events had taken oseltamivir beforehand].
    Tomono N; Shiro H
    Kansenshogaku Zasshi; 2008 Nov; 82(6):613-8. PubMed ID: 19086415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and outcome in 84 patients with influenza pneumonia].
    Takayanagi N; Hara K; Tokunaga D; Kato T; Kanazawa M; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2006 Oct; 44(10):681-8. PubMed ID: 17087332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing antibiotic use in influenza: challenges and rewards.
    Low D
    Clin Microbiol Infect; 2008 Apr; 14(4):298-306. PubMed ID: 18093237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 feeding enhances humoral immune responses, which are suppressed by the antiviral neuraminidase inhibitor oseltamivir in influenza A virus-infected mice.
    Takahashi E; Sawabuchi T; Kimoto T; Sakai S; Kido H
    J Dairy Sci; 2019 Nov; 102(11):9559-9569. PubMed ID: 31495632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of neuraminidase inhibitors for anti-influenza].
    Liu AL; Wang HD; Yang F; Du GH
    Yao Xue Xue Bao; 2009 Sep; 44(9):935-42. PubMed ID: 20055166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
    McCullers JA
    J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.